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Abstract
Background: In Malaysia, Shigella spp. was reported to be the third commonest bacterial agent
responsible for childhood diarrhoea. Currently, isolation of the bacterium and confirmation of the
disease by microbiological and biochemical methods remain as the "gold standard". This study
aimed to detect the prevalence of four Shigella virulence genes present concurrently, in randomly
selected Malaysian strains via a rapid multiplex PCR (mPCR) assay.
Methods: A mPCR assay was designed for the simultaneous detection of chromosomal- and
plasmid-encoded virulence genes (set1A, set1B, ial and ipaH) in Shigella spp. One hundred and ten
Malaysian strains (1997–2000) isolated from patients from various government hospitals were
used. Reproducibility and sensitivity of the assay were also evaluated. Applicability of the mPCR in
clinical settings was tested with spiked faeces following preincubation in brain heart infusion (BHI)
broth.
Results: The ipaH sequence was present in all the strains, while each of the set1A, set1B and ial
gene was present in 40% of the strains tested. Reproducibility of the mPCR assay was 100% and
none of the non-Shigella pathogens tested in this study were amplified. The mPCR could detect 100
colony-forming units (cfu) of shigellae per reaction mixture in spiked faeces following
preincubation.
Conclusions: The mPCR system is reproducible, sensitive and is able to identify pathogenic strains
of shigellae irrespective of the locality of the virulence genes. It can be easily performed with a high
throughput to give a presumptive identification of the causal pathogen.
Background
Members of the genus Shigella, namely S. flexneri, S. dys-
enteriae, S. sonnei and S. boydii have caused and continue
to be responsible for mortality and/or morbidity in high
risk populations such as children under five years of age,
senior citizens, toddlers in day-care centres, patients in
custodial institutions, homosexual men and, war- and
famine-engulfed people. Yearly episodes of shigellosis
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these, 163.2 million were in developing countries and the
remaining in industrialized nations. The mortality rate
was approximately 0.7% [1]. A recent study by Lee &
Puthucheary [2] on bacterial enteropathogens in child-
hood diarrhoea in a Malaysian urban hospital showed
that Shigella spp. was the third most common bacteria iso-
lated. S. flexneri and S. dysenteriae type 1 infections are
usually characterized by frequent passage of small
amounts of stool and mucus or blood. At times, watery
stool followed by typical dysenteric stool maybe present
with S. dysenteriae type 1 infection. S. sonnei and S. boydii
infections are less severe with watery faeces but little
mucus or blood.
Shigellosis is usually a self-limiting infection, however
when it subsides, the intestinal ulcers heal with scar tissue
formation. Uncomplicated recovery is usual and the
organisms rarely cause other types of infections.
Adversely, in 3 to 50% of cases, depending on the viru-
lence of the strain, the nutritional and immune status of
the host, the initial infection maybe followed by neuro-
logical complications or kidney failure. Serious complica-
tions do occur at greatest frequencies in malnourished
infants, toddlers, older adults and immunocompromised
individuals [3,4].
Virulence genes responsible for the pathogenesis of shig-
ellosis may be located in the chromosome or on the inv
plasmid borne by the organism. They are often multifac-
torial and coordinately regulated, and the genes tend to be
clustered in the genome. Previously reported PCR-based
detection methods concentrated mainly on the ipaH gene
alone [5,6] or on ipaH and ial genes in two separate PCR
assays [7,8]. As ial is found on the large inv plasmid which
is prone to loss or deletions, this gene-based detection
may give false negative results. ipaH, on the other hand, is
present on both the Shigella chromosome and on a large
plasmid and hence, it is a more stable gene to detect.
However, the sole presence of ipaH is not an absolute
indicator of virulence as loss or deletion of the plasmid
renders the bacterium noninvasive and therefore, aviru-
lent. set1A and set1B are chromosomal genes encoding
Shigella enterotoxin 1 (ShET1), which cause the watery
phase of diarrhoea in shigellosis [9,10]. ial and ipaH are
responsible for directing epithelial cell penetration by the
bacterium and for the modification of host response to
infection, respectively [11-13].
Here, we describe the application of a multiplex PCR
(mPCR) design for simultaneous detection of four viru-
lence genes (set1A, set1B, ial and ipaH) in Shigella spp. and
to determine the prevalence of these virulence genes in a
random selection of Malaysian Shigella strains.
Methods
Bacterial strains and growth conditions
A total of 110 Shigella strains of S. flexneri (n = 84), S. son-
nei (n = 15), S. dysenteriae (n = 10) and S. boydii (n = 1)
were used in this study. These strains were isolated from
patients with diarrhoea in Peninsular Malaysia from
1997–2000, and were provided by the Institute for Medi-
cal Research (IMR), Malaysia. Serotyping of the strains
(Shigella antisera from Mast Diagnostics, UK) was carried
out by the Bacteriological Unit, IMR. All the strains were
checked on Salmonella-Shigella (SS) agar before being
transferred to Luria Bertani (LB) agar plate, incubated
overnight at 37°C for subsequent screening of virulence-
associated genes. All strains were stored at -20°C in LB
broth containing 15% glycerol.
Development of mPCR
Boiled suspension of bacterial cells was used as DNA tem-
plate. Previously described primers, obtained from Inte-
grated DNA Techs, USA, for detection of the four virulence
genes were applied to the template [8,14,15] (Table 1).
Prior to combining all the four primer sets in an mPCR,
each pair of primers was optimized singly in separate PCR
assays. A typical 25-µl PCR reaction mixture for every
primer set consisted of 1x PCR buffer B (Promega, USA),
4 mM MgCl2, 130 µM of each deoxynucleotide (dNTP),
0.5 µM of each primer, 1 U of Taq DNA polymerase
(Promega, USA) and 2 µl of DNA template. Amplifica-
tions were carried out using a Robocycler Gradient 40
Temperature Cycler (Strategene Cloning Systems, USA).
The cycling conditions were an initial denaturation at
95°C for 5 min, template denaturation at 95°C for 50 s,
annealing at 55°C for 1.5 min, and extension at 72°C for
2 min for a total of 30 cycles, with a final extension at
72°C for 7 min.
Based on the results of individual priming, an mPCR was
designed. Various parameters such as concentrations of
primers (0.5–0.8 µM), MgCl2 (2 to 4 µM), Taq DNA
polymerase (0.6 to 4 U) and dNTPs (100–150 µM) and
buffer strength (1.4X to 2.4X) were tested. The simultane-
ous gene amplifications were performed in a reaction vol-
ume of 25 µl consisting of 1.8X PCR buffer B (Promega,
USA), 4 mM MgCl2, 130 µM of each dNTP, 0.3 µM of each
ShET1B primer, Shig1 and Shig2 primers, 0.5 µM of each
ShET1A and ial primers, 1 U of Taq DNA polymerase
(Promega, USA) and 2 µl of DNA template. All the reac-
tion mixtures were overlaid with 20 µl of sterile mineral
oil. Amplifications were similarly carried out as above.
After initial screening, strain TH13/00 (S. flexneri 2a) was
chosen as a positive control for PCR assays. A negative
control using sterile distilled water as template was
included in every PCR assay. The DNA fragments were
separated in 2% agarose gel.Page 2 of 7
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The mPCR assay was repeated at least twice with 28 strains
to determine the reproducibility of the results, whereby
the DNA template of a particular strain was freshly pre-
pared for each repeat.
Specificity test
The specificity of the mPCR assay was tested with 12 other
non-Shigella pathogens: Enterobacter cloacae, Salmonella
Paratyphi A (ATCC 9281), S. Paratyphi C, S. Typhimu-
rium, S. Enteritidis, S. Typhi (ATCC 7251), Listeria mono-
cytogenes, Pseudomonas aeruginosa, Klebsiella pneumoniae,
Citrobacter freundii, Escherichia coli O157:H7 and E. coli
O78:H11.
Faecal spiking and sensitivity test
This was based on a modification of that described by
Chiu and Ou [16]. Approximately 0.2 g of faeces from a
healthy individual was suspended in 1 ml of brain heart
infusion (BHI) (Oxoid Ltd., UK) and diluted 10-fold.
Then, 1 ml of the diluted faecal suspension was inocu-
lated into 4 ml of BHI and vortexed to obtain a homoge-
nous mixture of broth-faecal suspension. Meanwhile, an
overnight culture of S. flexneri 2a was harvested and seri-
ally diluted 10-fold with BHI. Then, 250 µl of each dilu-
tion of cell culture was mixed with 250 µl of the broth-
faecal suspension and 500 µl of BHI in a new eppendorf
tube. The tubes were vortexed and preincubated at 37°C
for 4 h without shaking. Simultaneously, 100 µl of each
diluted culture was plated on LB agar (Oxoid Ltd., UK) to
determine the number of viable bacteria in each dilution.
After preincubation, mPCR assay was performed on the
boiled lysates of each diluted culture. A pure culture of S.
flexneri 2a (TH13/00) and an unspiked faecal sample
served as positive and negative controls.. The test was
repeated with a spiked faecal sample of another healthy
individual, and the average detection limit was reported.
Screening of clinical specimens
0.2 g of each faecal sample from 10 patients suffering
from diarrhoea in a local tertiary University Hospital was
suspended in 1 ml of BHI and diluted 10-fold. A volume
of 250 µl of broth-faecal suspension was inoculated into
5 ml of BHI and preincubated at 37°C for 4 h without
shaking. Concurrently, 100 µl of the suspension was
plated onto MacConkey and SS agar plates and incubated
overnight at 37°C. mPCR assay was performed on the
boiled lysate of the broth-faecal suspension after preincu-
bation. A pure culture of strain TH13/00 and a Shigella-
spiked faecal sample served as a positive control, whilst a
PCR reaction mixture without bacterial DNA template
and an unspiked faecal sample from a healthy individual
acted as a negative control.
Results
Optimization strategies
A monoplex PCR for each primer set was initially carried
out based on a published report [17]. Although the con-
centrations of MgCl2 (3 mM), dNTP (400 µM each) and
primers (1 µM each) were used as recommended, unspe-
cific bands were present together with intense primer-
dimers. In order to reduce the background noise and
primer-dimers, concentrations of 0.5 µM of each primer
and 200 µM of each dNTP were used. Further optimiza-
tions of MgCl2 concentrations (2 to 4 µM) and dNTP
(100,130 and 150 µM each) gave intense amplicons with
a clean background in each monoplex amplification (Fig
1, lanes 1–4).
Table 1: Primers used to identify various virulence-associated genes of Shigella spp.
Primer Virulence gene Nucleotide sequences (5' → 3') Size of amplicon (bp) Reference
ShET1A set1A TCA CGC TAC CAT CAA
AGA
TAT CCC CCT TTG GTG
GTA
309 14
ShET1B set1B GTG AAC CTG CTG CCG
ATA TC
ATT TGT GGA TAA AAA
TGA CG
147 14
ial ial CTG GAT GGT ATG GTG
AGG
GGA GGC CAA CAA TTA
TTT CC
320 15
Shig1 ipaH TGG AAA AAC TCA GTG
CCT CT
423 8
Shig2 CCA GTC CGT AAA TTC
ATT CTPage 3 of 7
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single reaction using the reaction condition in monoplex
PCR were not successful. A common practice in mPCRs
involving any non-amplification of a required gene
('weak locus') is to increase the amount of primers of the
gene at same time with a decrease of the amount of prim-
ers for all the loci that can be amplified, especially those
with strong amplifications. Hence, the concentrations of
primers for both ipaH (Shig) and set1B (ShET1B) were
reduced to 0.3 µM each and the primers for both set1A
(ShET1A) and ial (ial) genes were maintained at 0.5 µM
each. Following optimization of the concentrations of Taq
DNA polymerase (0.6 to 4U/25 µL), buffer strength (1.4
X to 2.4 X), dNTPs (140 to 220 µM) and annealing tem-
peratures (49 to 59°C) (at a constant MgCl2 concentration
of 4 mM), a more uniform amplification of all the genes
with no background noise was obtained (Fig. 1 lane 5) at
a final buffer concentration of 1.8X, 1 U Taq DNA
polymerase, 130 µM dNTP each and annealing tempera-
ture of 55°C.
Prevalence of virulence genes in the Malaysian strains
All the 110 strains of Shigella spp. tested showed the pres-
ence of ipaH (Table 2). Conversely, only 41% of the
strains had both set1A and set1B genes, and ial gene.
Almost all the Shigella strains tested positive for the tan-
dem genes (87%) belonged to S. flexneri 2a serotype.
Among the predominant strains of Shigella flexneri in
Malaysia, ial was found in serotypes 4a, 6, 3a, 2a, 1a and
3c. All the four genes were present only in S. flexneri 2a
and 3a.
Reproducibility
Reproducibility for the detection ofset1A, set1B, ial and
ipaH genes assayed in the mPCR was 100%. None of the
non-Shigella strains tested gave any amplification (data
not shown).
Sensitivity
The mPCR assay was tested on 10-fold dilutions of an
overnight culture of S. flexneri 2a. All the four virulence-
associated genes were detected until 10-3 dilutions (data
not shown). This was equivalent to 2.45 × 105 lysate or a
minimum of 490 cfu of shigellae per 25 -µLmPCR
reaction.
Faecal spiking and sensitivity
An initial experiment using undiluted spiked faecal sam-
ple failed to give any PCR amplification (data not shown).
When the faecal suspension was diluted and preincubated
in BHI for 4 h, the mPCR assay was successful in detecting
the presence of the four virulence genes at an average con-
centration of 5.0 × 104 colony-forming units (cfu) shigel-
lae ml-1 or approximately 100 cfu per reaction mixture
(Fig. 2 lane 8).
Clinical specimens
A preliminary study on the efficacy of the mPCR assay in
the direct detection of the aforementioned Shigella viru-
lence genes on faecal samples was tested on ten diarrhoeal
patients. No mPCR product was detected although both
the positive controls had amplifications. By conventional
culture method, there was no growth of Shigella on the LB,
MacConkey and SS agar plates.
Ethidium bromide-stained agarose gel showing PCR productsFigure 1
Ethidium bromide-stained agarose gel showing PCR 
products. Lane M, 100-bp DNA ladder (Promega); lane 1, 
set1B gene product; lane 2, set1A gene product; lane 3, ial 
gene product; lane 4, ipaH gene product; lane 5, mPCR 
product.
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S. flexneri 1a 3 0 (0) 0 (0) 1 (33) 3 (100)
1b 3 0 (0) 0 (0) 0 (0) 3 (100)
2a 47 41 (87) 41 (87) 19 (40) 47 (100)
3a 18 3 (17) 3 (17) 12 (67) 18 (100)
3c 10 0 (0) 0 (0) 1 (10) 10 (100)
4a 1 1 (100) 1 (100) 1 (100) 1 (100)
6 1 0 (0) 0 (0) 1 (100) 1 (100)
y 1 0 (0) 0 (0) 0 (0) 1 (100)
S. sonnei 15 0 (0) 0 (0) 2 (13) 15 (100)
S. dysenteriae 2 10 0 (0) 0 (0) 8 (80) 10 (100)
S. boydii 6 1 0 (0) 0 (0) 0 (0) 1 (100)
Total 110 45 45 45 110Page 4 of 7
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Numerous studies had been performed to detect virulence
genes in Shigella by monoplex PCRs [8,17,18]. Studies
involving the combination of chromosomal- and plas-
mid-encoded virulence genes in a single assay for Shigella
detection, on the other hand, are scarce. Although the
optimization of mPCR is more tedious and difficult to
achieve than monoplexes, the ease of screening a large
number of specimens, once the system is optimized, far
outweighs the initial problems. The present mPCR system
encompasses the presence of virulence genes found in the
Shigella chromosome and on the large inv plasmid. Hence,
it can determine if the pathogenesis of a particular strain
is attributable to its chromosome or the plasmid, or if the
strain is still invasive or otherwise, in a single reaction.
Initially, the monoplex PCRs were carried out following
reaction conditions as proposed by a previous report [17].
However, we could not reproduce their results and hence
had to modify the PCR conditions. Our failure to repro-
duce identical results despite using similar reagent con-
centrations and amplification conditions maybe
attributed to the different makes of PCR reagents and
primers used. Broude et al. [19] had compared amplifica-
tion efficiencies of two commercial Taq DNA polymerases
and found that they displayed different specificity in PCR.
Preferential amplification of one target sequence over
another is a known phenomenon in mPCRs and it is usu-
ally overcome by increasing the amount of primers for the
weaker amplification simultaneously with a decrease of
Faecal-spiking and sensitivity result of mPCRigure 2
Faecal-spiking and sensitivity result of mPCR. Lane M, 100-bp DNA ladder (Promega, USA); lane 1, TH13/00 (positive 
control); lane 2, unspiked faeces (negative control); lane 3, undiluted spiked faeces; lane 4, 10-1 dilution; lane 5, 10-2 dilution; 
lane 6, 10-3 dilution; lane 7, 10-4 dilution; lane 8, 10-5 dilution; lane 9, 10-6 dilution; lane 10, 10-7 dilution; lane 11, 10-8 dilution; 
lane 12, 10-9 dilution; lane 13, 10-10 dilution; lane 14, "water blank".
M    1   2    3   4    5    6   7    8   9  10  11 12  13  14   M 
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Buffer concentration may also affect mPCR amplifications
despite it being seldom considered during monoplex opti-
mization works [20]. Upon adjustment of primers and
buffer concentrations, specific and consistent amplifica-
tion of all the genes in the multiplex combination was
achieved.
Although other studies have demonstrated the presence of
ial and ipaH in strains of enteroinvasive Escherichia coli
(EIEC) [11,13,21], we had not applied the mPCR assay to
EIEC strains. It is unfortunate that these strains were not
available for our study as EIEC gives rise to similar illness
as Shigellosis.
Our study supported the observations of Noriega et al. [9]
and Vargas et al. [17] in local Shigella strains. Their studies
showed that both set1A and set1B were present exclusively
in S. flexneri 2a. The complete correlation between the
presence of both set1A and set1B showed that both genes
are indeed found in tandem in the Shigella genome. In this
study, almost all the Shigella strains positive for the pres-
ence of set1A and set1B (41/45 strains) belonged to S.
flexneri 2a, thus confirming previous works that both
genes are highly conserved in this particular serotype [14].
Both the prevalence of ial and ipaH were independent of
the four different species of Shigella tested. Though both
ial and ipaH are responsible for invasion-related processes
and are found on the inv plasmid, the ial gene cluster
resides near a region of the plasmid, which is a hot spot
for spontaneous deletions [22]. This probably explains
the lower prevalence of ial (45/110 strains) than ipaH
(110/110 strains) in the Malaysian Shigella strains. Since
invasiveness is a prerequisite for virulence in shigellae and
since most of these virulence genes are located on the
large plasmid, these strains would have possessed the
plasmid when first isolated from patients. Due to storage/
subculturing, the plasmid might have been lost together
with the virulence-associated genes. By virtue of multiple
copies being present on both the chromosome and the inv
plasmid [23], ipaH seemed to be less compromised by
plasmid loss and/or deletions. As the sole presence of
ipaH is not indicative of the invasive phenotype, our
mPCR design, which incorporated three other virulence
genes, could determine the invasiveness of Shigella strains
in epidemiological studies.
Dilution of the faecal sample with BHI was performed to
lower the levels of PCR inhibitors such as bilirubin, bile
salts and heme in the faeces [16]. An additional step of
preincubating the spiked faecal samples also helped to
eliminate the natural inhibitors [24]. The short 4-h
enrichment step would increase the total number of target
sequences caused by more bacterial growth and the over-
all detection sensitivity of the assay. Although PCR cannot
differentiate between dead and viable bacteria, enrich-
ment helped to dilute the concentrations of dead bacteria,
thus reducing the probability of detecting them by the
subsequent mPCR assay. The sensitivity level achieved in
the study was found to be comparable to other studies.
Houng et al. [25] detected up to 7.4 × 104 cfu shigellae ml-
1 by amplifying the IS 630 sequences in shigella spp.. Yav-
zori et al. [24] reported a detection level of 104 cfu shigellae
per gram of faeces with the use of virF primers. Although
it has been reported that ingestion as low as 100 shigellae
resulted in clinical disease [26], the highest percentage of
volunteers having diarrhoea were administered doses of at
least 104 viable organisms. Thus, the average detection
limit of mPCR described in this study (5.0 × 104 cfu/ml)
is within the common infectious dose for shigellae.
Results from the preliminary clinical screening were
promising. Nevertheless, the consideration of other
diarrhoeal pathogens being present in the clinical samples
cannot be negated. More patient samples are warranted to
thoroughly vet the robustness and applicability of the
developed mPCR in clinical environments.
One limitation of the present mPCR system is its inability
to differentiate Shigella spp., unlike the multiplex reac-
tions based on specific rfc genes developed by Houng et al.
[25]. For future research, either set1A or set1B may be
omitted from the multiplex system as both genes are
shown to exist tandemly. rfc primers of different Shigella
origins maybe incorporated to enable the discrimination
of Shigella spp. as well as the identification of virulent
strains in one assay.
Conclusions
We conclude that the mPCR system is able to identify
pathogenic strains of shigellae irrespective of the locality
of the virulence genes. The described assay is reproduci-
ble, sensitive, can be easily performed and is able to give
a presumptive identification of the causal pathogen,
which could be confirmed by culture techniques using
selective media. An added advantage would be that EIEC,
which gives a similar illness, might also be detected by
this method, as EIEC also harbours ial and ipaH genes.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
SLLH carried out the experiments, data analysis and wrote
the manuscript. RMY provided the bacterial strains. SDP
contributed to the writing of the manuscript. TKL con-
ceived and co-designed the study, provided input for writ-Page 6 of 7
(page number not for citation purposes)
BMC Infectious Diseases 2005, 5:8 http://www.biomedcentral.com/1471-2334/5/8Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
ing and supervision of the study. All authors read and
approved the final manuscript.
Acknowledgements
IRPA grant (06-02-03-1007) from the Ministry of Science, Technology and 
Environment, Malaysia and Vote F (F0144/2002B) from the University of 
Malaya, Malaysia, supported this work. We are grateful to Mr. Koh Yin Tee 
(IMR) for serotyping the bacterial strains.
References
1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, San-
sonetti PJ, Adak GK, Levine MM: Global burden of Shigella infec-
tions: implications for vaccine development and
implementation of control strategies. Bull World Health Organ
1999, 77:651-666.
2. Lee WS, Puthucheary SD: Bacterial enteropathogens isolated in
childhood diarrhoea in Kuala Lumpur – the changing trend.
Med J Malaysia 2002, 57:24-30.
3. Salyers AA, Whitt DD: Bacterial pathogenesis: a molecular approach
Washington, DC, ASM Press; 1994. 
4. Khan AM, Rabbani GH, Faruque ASG, Fuchs GJ: WHO-ORS in
treatment of shigellosis. J Diarrhoeal Dis Res 1999, 17:88-89.
5. Gaudio PA, Sethabutr O, Echeverria P, Hoge CW: Utility of a
polymerase chain reaction diagnostic system in a study of
the epidemiology of shigellosis among dysentery patients,
family contacts and well controls living in a shigellosis-
endemic area. J Infect Dis 1997, 176:1013-1018.
6. Dutta S, Chatterjee A, Dutta P, Rajendran K, Roy S, Pramanik KC,
Bhattacharya SK: Sensitivity and performance characteristics
of a direct PCR with stool samples in comparison to conven-
tional techniques for diagnosis of Shigella and enteroinvasive
Escherichia coli infection in children with acute diarrhoea in
Calcutta, India. J Med Microbiol 2001, 50:667-674.
7. Sethabutr O, Venkatesan M, Murphy GS, Eampokalap B, Hoge CW,
Echeverria P: Detection of shigellae and enteroinvasive
Escherichia coli by amplification of the invasive plasmid anti-
gen H DNA sequence in patients with dysentery. J Infect Dis
1993, 167:458-461.
8. Lüscher D, Altwegg M: Detection of shigellae, enteroinvasive
and enterotoxigenic Escherichia coli using the polymerase
chain reaction (PCR) in patients returning from tropical
countries. Mol Cell Probes 1994, 8:285-290.
9. Noriega FR, Liao FM, Formal SB, Fasano A, Levine MM: Prevalence
of Shigella enterotoxin 1 among Shigella clinical isolates of
diverse serotypes. J Infect Dis 1995, 172:1408-1410.
10. Rhee SJ, Wilson KT, Gobert AP, Nataro JP, Fasano A: The entero-
toxic activity of Shigella enterotoxin 1 (ShET1) is mediated
by inducible nitric oxide synthase activity. J Pediatr Gastroenterol
Nutr 2001, 33:400-416.
11. Frankel G, Riley L, Giron JA, Valmassoi J, Friedmann A, Strockbine N,
Falkow S, Schoolnik GK: Detection of Shigella in feces using
DNA amplification. J Infect Dis 1990, 161:1252-1256.
12. Ménard R, Prévost MC, Gounon P, Sansonetti P, Dehio C: The
secreted Ipa complex of Shigella flexneri promotes entry into
mammalian cells. Proc Natl Acad Sci USA 1996, 93:1254-1258.
13. Hale TL: Genetic basis of virulence in Shigella species. Microbiol
Rev 1991, 55:206-224.
14. Fasano A, Noriega FR, Maneval DR Jr, Chanasongcram S, Russell R,
Guandalini S, Levine MM: Shigella enterotoxin 1: an enterotoxin
of Shigella flexneri 2a active in rabbit small intestine in vivo
and in vitro. J Clin Invest 1995, 95:2853-2861.
15. Frankel G, Giron JA, Valmassoi J, Schoolnik GK: Multi-gene ampli-
fication: simultaneous detection of three virulence genes in
diarrhoeal stool. Mol Microbiol 1989, 3:1729-1734.
16. Chiu CH, Ou JT: Rapid identification of Salmonella serovars in
feces by specific detection of virulence genes, invA and spvC,
by an enrichment broth cultivation-multiplex PCR combina-
tion assay. J Clin Microbiol 1996, 34:2619-2622.
17. Vargas M, Gascon J, De Anta MTJ, Vila J: Prevalence of Shigella
enterotoxins 1 and 2 among Shigella strains isolated from
patients with traveler's diarrhea. J Clin Microbiol 1999,
37:3608-3611.
18. Gaudio PA, Sethabutr O, Echeverria P, Hoge CW: Utility of a
polymerase chain reaction diagnostic system in study of the
epidemic of shigellosis among dysentery patients, family
contacts and well controls living in a shigellosis-endemic
area. J Infect Dis 1997, 176:1013-1018.
19. Broude NE, Zhang L, Woodward K, Englert D, Cantor CR: Multi-
plex allele-specific target amplification based on PCR
suppression. Proc Natl Acad Sci USA 2001, 98:206-211.
20. Henegariu O, Heerema NA, Diouhy SR, Vance GH, Vogt PH: Multi-
plex PCR: critical parameters and step-by-step protocol. Bio-
Techniques 1997, 23:504-511.
21. Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD, Noriega F,
Dubovsky R, Levine MM, Morris JG Jr: Identification and cloning
of a novel plasmid-encoded enterotoxin of enteroinvasive
Escherichia coli and Shigella strains. Infect Immun 1995,
63:4721-4728.
22. Sasakawa C, Kamata K, Sakai T, Murayama SY, Makino S, Yoshikawa
M: Molecular alteration of the 140-megadalton plasmid asso-
ciated with loss of virulence and Congo red binding activity
in Shigella flexneri. Infect Immun 1986, 51:470-475.
23. Venkatesan M, Buysse JM, Kopecko DJ: Use of Shigella flexneri
ipaC and ipaH gene sequences for the general identification
of Shigella spp. and enteroinvasive Escherichia coli. J Clin
Microbiol 1989, 27:2687-2691.
24. Yavzori M, Cohen D, Wasserlauf R, Ambar R, Rechavi G, Ashkenazi
S: Identification of Shigella species in stool specimens by DNA
amplification of different loci of the Shigella virulence
plasmid. Eur J Clin Microbiol Infect Dis 1994, 13:232-237.
25. Houng HSH, Sethabutr O, Echeverria P: A simple polymerase
chain reaction technique to detect and differentiate Shigella
and enteroinvasive Escherichia coli in human feces. Diagn
Microbiol Infect Dis 1997, 28:19-25.
26. DuPont HL, Levine MM, Hornick RB, Formal SB: Inoculum size in
shigellosis and implications for expected mode of
transmission. J Infect Dis 1989, 159:1126-1128.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/5/8/prepubPage 7 of 7
(page number not for citation purposes)
